论文部分内容阅读
目的研究阿托伐他汀与阿司匹林联合对中风发作期痰瘀互结型患者hs-CRP、GMP140的影响。方法选取我院2013年6月至2014年6月收治的中风发作期痰瘀互结型患者100例为研究对象,将其随机分为两组,对照组给予阿司匹林治疗,观察组给予阿托伐他汀与阿司匹林联合治疗,对比两组效果。结果治疗后观察组患者的GMP140以及hs-CRP水平显著低于对照组。结论阿托伐他汀与阿司匹林联合能够显著降低中风发作期痰瘀互结型患者的hs-CRP、GMP140水平。
Objective To investigate the effects of combination of atorvastatin and aspirin on hs-CRP and GMP140 in patients with phlegm and blood stasis syndrome during stroke. Methods A total of 100 cases of patients with phlegm and blood stasis type in our hospital from June 2013 to June 2014 were selected and divided into two groups randomly. The control group was treated with aspirin. The observation group was given atorvastatin Statin and aspirin combination therapy, compared two sets of effects. Results After treatment, the levels of GMP140 and hs-CRP in the observation group were significantly lower than those in the control group. Conclusions Atorvastatin combined with aspirin can significantly reduce hs-CRP and GMP140 levels in patients with phlegm and blood stasis syndrome in stroke episodes.